These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 27461631)
41. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis. An PP; Feng LN; Zhang XX; Jin QL Medicine (Baltimore); 2020 Dec; 99(50):e23659. PubMed ID: 33327352 [TBL] [Abstract][Full Text] [Related]
42. Murine double minute 2 rs2279744 polymorphism and hepatocellular carcinoma risk in East Asians: a meta-analysis. Liu Y; Kuang S; Zheng J; Zheng J; Jin H; Chen S; Jian Z Tumour Biol; 2014 Feb; 35(2):961-5. PubMed ID: 24061636 [TBL] [Abstract][Full Text] [Related]
43. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis. Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578 [TBL] [Abstract][Full Text] [Related]
44. High-resolution melting analysis reveals genetic polymorphisms in microRNAs confer hepatocellular carcinoma risk in Chinese patients. Qi JH; Wang J; Chen J; Shen F; Huang JT; Sen S; Zhou X; Liu SM BMC Cancer; 2014 Aug; 14():643. PubMed ID: 25176041 [TBL] [Abstract][Full Text] [Related]
45. Effects of common polymorphisms rs2910164 in miR-146a and rs3746444 in miR-499 on cancer susceptibility: a meta-analysis. Yin Z; Yan L; Cui Z; Li X; Ren Y; Zhou B Mol Biol Rep; 2013 Apr; 40(4):3003-13. PubMed ID: 23292097 [TBL] [Abstract][Full Text] [Related]
46. Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis. Wang Z; Cao Y; Jiang C; Yang G; Wu J; Ding Y PLoS One; 2012; 7(6):e40039. PubMed ID: 22768213 [TBL] [Abstract][Full Text] [Related]
47. Association of two polymorphisms rs2910164 in miRNA-146a and rs3746444 in miRNA-499 with rheumatoid arthritis: a meta-analysis. Li K; Tie H; Hu N; Chen H; Yin X; Peng C; Wan J; Huang W Hum Immunol; 2014 Jul; 75(7):602-8. PubMed ID: 24824381 [TBL] [Abstract][Full Text] [Related]
48. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk. Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482 [TBL] [Abstract][Full Text] [Related]
49. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis. Duan CY; Liu MY; Li SB; Ma KS; Bie P Tumour Biol; 2014 Jan; 35(1):659-66. PubMed ID: 23955801 [TBL] [Abstract][Full Text] [Related]
50. Association between IRAK1 rs3027898 and miRNA-499 rs3746444 polymorphisms and rheumatoid arthritis : A case control study and meta-analysis. Yang XK; Li P; Zhang C; Leng RX; Li S; Liu J; Li BZ; Pan HF; Ye DQ Z Rheumatol; 2017 Sep; 76(7):622-629. PubMed ID: 27581002 [TBL] [Abstract][Full Text] [Related]
51. Significant association between functional microRNA polymorphisms and head and neck cancer susceptibility: a comprehensive meta-analysis. Niu YM; Du XY; Lu MY; Xu QL; Luo J; Shen M Sci Rep; 2015 Aug; 5():12972. PubMed ID: 26277865 [TBL] [Abstract][Full Text] [Related]
52. Association between the Interleukin-10 -1082 G/A polymorphism and risk of hepatocellular carcinoma. Wang Y; Hu P Afr Health Sci; 2020 Mar; 20(1):351-358. PubMed ID: 33402922 [TBL] [Abstract][Full Text] [Related]
53. MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis. Liu GY; Jiang DK; Shen SQ; Yu L Arch Med Res; 2011 Feb; 42(2):149-55. PubMed ID: 21565629 [TBL] [Abstract][Full Text] [Related]
54. hOGG1 Ser326Cys polymorphism and risk of hepatocellular carcinoma among East Asians: a meta-analysis. Wang W; Dang S; Li Y; Sun M; Jia X; Wang R; Liu J PLoS One; 2013; 8(4):e60178. PubMed ID: 23577090 [TBL] [Abstract][Full Text] [Related]
55. Significant association between XRCC3 C241T polymorphism and increased risk of hepatocellular carcinoma: a meta-analysis. Wu D; Jiang H; Yu H; Xu D; Liang J; Jin J Tumour Biol; 2013 Dec; 34(6):3865-9. PubMed ID: 23873110 [TBL] [Abstract][Full Text] [Related]
56. Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of hepatocellular carcinoma. Song K; Yi J; Shen X; Cai Y PLoS One; 2012; 7(11):e48924. PubMed ID: 23185284 [TBL] [Abstract][Full Text] [Related]
57. [Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma: a meta-analysis]. Zhang LH; Zhang CY; Dai XZ; Zhang J; Zhang F Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):749-754. PubMed ID: 29108203 [No Abstract] [Full Text] [Related]
58. Association of GST genetic polymorphisms with the susceptibility to hepatocellular carcinoma (HCC) in Chinese population evaluated by an updated systematic meta-analysis. Liu K; Zhang L; Lin X; Chen L; Shi H; Magaye R; Zou B; Zhao J PLoS One; 2013; 8(2):e57043. PubMed ID: 23437305 [TBL] [Abstract][Full Text] [Related]
59. Tumor Necrosis Factor-Alpha Gene Promoter (TNF-α G-308A) Polymorphisms Increase the Risk of Hepatocellular Carcinoma in Asians: A Meta-Analysis. Verma HK; Merchant N; Bhaskar LVKS Crit Rev Oncog; 2020; 25(1):11-20. PubMed ID: 32865907 [TBL] [Abstract][Full Text] [Related]
60. Lack of association of MiR-34b/c polymorphism (rs4938723) with hepatocellular carcinoma: a meta-analysis. Liang TJ; Liu HJ; Zhao XQ; Yu CH; Li CS PLoS One; 2013; 8(7):e68588. PubMed ID: 23935875 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]